About this trial
The purpose of this study is to evaluate the superiority of IV lidocaine combined with morphine spinal anesthesia versus placebo combined with morphine spinal anesthesia, in reducing postoperative morphine consumption at 48 hours, in patients undergoing major digestive or abdominal surgery by laparotomy.
Eligibility criteria
Qualifiers
Age ≥ 18 years;
Major digestive or abdominal surgery (pancreatic, hepatic, colorectal, gynecological, esophageal, gastric, duodenal, small intestine...);
Scheduled surgery;
Laparotomy;
Disqualifiers
Emergency surgery;
Contraindication to non-steroidal anti-inflammatory drugs: history of gastro duodenal ulcer, renal failure from stage 3 A or higher;
History of bradycardia and/or known conduction disorder (atrioventricular block) / Pacemaker ;
Unstable coronary ;
Trial design
Treatments tested in this trial
- rachi morphine anesthesia
- laparotomy
- Lidocaine IV
- Placebo
- MORPHINE
Treatment groups
Locations
1Sponsors and collaborators
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator